Significant correlation has been found between homocysteine concentration and. Behind only alzheimers disease, vascular contributions to cognitive impairment and dementia vcid is the second most common cause of dementia, affecting roughly 1040% of. Some experts believe, however, that there is insufficient evidence to link. Homocysteine thcy is an intermediate sulfurcontaining amino acid produced from methionine during processing of dietary proteins. The controversial role of homocysteine in neurology. Hyperhomocysteinemia in chronic renal insufficiency in.
Conclusionslowering of homocysteine with folic acid and vitamins b6 and b12 did reduce the risk of overall stroke, but not stroke severity or disability. Hyperhomocysteinemia in patients with acute ischaemic. Current areas of investigation in the lentz lab include the following. Aug 15, 2003 hyperhomocysteinemia was present in combination with other types of thrombophilia in 11 patients 4 had also factor v leiden, 4 prothrombin mutation, 1 both, and 2 antiphospholipid antibodies and in no control subjects. Although hyperhomocysteinemia hyperhcy may predispose to atherosclerosis and venous thrombosis, the mechanisms of stroke associated with hyperhcy are not defined. Ahaasa guidelines for stroke prevention in patients with. Sufferers are generally asymptomatic until the onset of premature arterial disease later in life. Homocysteine hcy is a sulfurcontaining amino acid that is generated during methionine metabolism. Hyperhomocysteinemia hhcy, as a consequence of impaired hcy metabolism or defects in crucial cofactors that participate in its recycling, is assumed as an independent human stroke risk factor. Hyperhomocysteinemia and its implications in atherosclerosis. Hyperhomocysteinemia has been suspected of favoring thrombosis. Hyperhomocysteinemia is a risk factor for cardiovascular disease.
To study homocysteine levels in patients with ischemic stroke and compare it with age and sexmatched controls. Normally, these metabolites are not found in appreciable quantities in blood or urine. Hyperhomocysteinemia symptoms, diagnosis, treatments and. Homocysteine is a naturallyoccurring amino acid produced from a methyl donor, methionine and essential for intracellular metabolism 1. Pdf epidemiologic studies have identified hyperhomocysteinemia as a possible risk factor for atherosclerosis. Much evidence has shown that homocysteine hcy, a sulfurcontaining amino acid, is shown to be associated with cerebrovascular diseases,1, 2, 3 and an independent predictor of poor. Hyperhomocysteinemia, oxidative stress, and cerebral. Some experts believe, however, that there is insufficient evidence to link hyperhomocysteinemia to thrombosis definitively. Soomro, kanwal sartaj, shafaq alvi 1resident, department of medicine, ziauddin. Hyperhomocysteinemia as a risk factor for ischemic stroke. Clinical manifestations of homocystinuria include developmental delay, marfanoid appearance. Homocysteine hcy is a toxic, sulfurcontaining intermediate of methionine metabolism.
Hyperhomocysteinemia, obesity and cryptogenic stroke ios press. Homocystinuria is a rare autosomal recessive disorder characterized by severe elevations in plasma and urine homocysteine concentrations. Hyperhomocysteinemia has been proposed as an important risk factor for ischemic stroke worldwide, but data available from the indian subcontinent is scarce. Severity of symptoms is determined by how high the. Homocystinuria is an autosomal recessively inherited. Grewal3, marjorie busby4, patricia chang 4 and alan hinderliter 1.
Physiologic hcy levels are determined primarily by dietary intake and vitamin status. Hyperhomocysteinemia and vitamin b12 deficiency in. Epidemiological studies have shown that increased homocysteine plasma concentration hyperhomocysteinemia is related to a higher risk of coronary heart disease, stroke, peripheral vascular disease and malignancies. To answer the question directly, hyperhomocysteinemia is a significant risk factor for ischemic stroke as well as vascular events after the initial stroke stroke recurrence, ischemic heart. Homocysteine hcys is a key metabolite involved in the. Elevated plasma levels of homocysteine, termed hyperhomocysteinemia hhcy, are a major, yet underrecognized, risk factor for vcid. Nov 23, 2016 hyperhomocysteinemia hhcy, as a consequence of impaired hcy metabolism or defects in crucial cofactors that participate in its recycling, is assumed as an independent human stroke risk factor. In a large populationbased study,the plasma level ofhcy was reported to be an independent risk factor for chd in asian indians in the uk predominantly ofnorth indian descent 18 and hyperhomocysteinemia was attributed to low. Hyperhomocysteinemia an unidentified risk factor for. In adults with a recent ischemic stroke or tia who are known to have mild to moderate hyperhomocysteinemia, supplementation with folate, vitamin b6, and vitamin b12 safely reduces levels of homocysteine but has not been. Because of the low cost and safety of the therapy, the american heart and stroke association advises to treat patients with a stroke and hyperhomocysteinemia.
Clinical studies suggested that acute ischemic stroke patients with hyperhomocysteinemia hhcy are at an increased risk for early neurological deterioration, 4 longterm mortality, 5 and poor function outcome,6, 7 whereas other studies observed no association between hhcy and stroke outcome. Features, symptoms, and neurophysiological findings in stroke. We aimed to determine homocysteine levels in patients with cryptogenic stroke. Since the homocysteine level is elevated in patients with. While there is no cure for vcid, several risk factors for vcid, such as diabetes, hypertension, and stroke, have been identified. Mar 10, 20 hyperhomocysteinemia implications in neurology. The aims of our study were to assess i the association between risk of stroke and increasing values of plasma homocysteine and ii the interaction between mild hyperhomocysteinemia and conventional vascular risk factors. The mean plasma homocysteine level of the stroke patients was. The or for cerebral vein thrombosis associated with isolated hyperhomocysteinemia was 5. Clinical and biochemical phenotypes and genetic features of three unrelated patients with premature stroke and severe hyperhcy due to cystathionine betasynthase cbs deficiency are described.
Hyperhomocysteinemia may predispose to arterial thrombosis and venous thromboembolism by injuring vascular endothelial cells. There are significant differences in stroke patterns between patients with and without hyperhomocysteinemia, with a higher rate of lesions typical of cerebral microangiopathy and a trend to multiple infarctions in the former. Routine screening for hyperhomocysteinemia among patients with a recent ischemic stroke or tia is not indicated. Hyperhomocysteinemia in patients with acute ischaemic stroke. Hyperhomocysteinemia is an independent risk factor for premature cardiovascular disease. The oc currence and development of csvd are related to age, gender, hypertension, hyperglycemia, hyperlipidemia, smoking, etc. Hyperhomocysteinemia in ischaemic stroke patients has been determined as vascular risk factor in our study. Homocysteine levels of subjects with stroke were compared with 34 control subjects matched for age 18 men, 16 women 66 8 hcys 9. This disorder is associated with several vascular, neurological, and skeletal problems including stroke, heart attack, clotting, mental retardation, eye abnormalities, and osteoporosis, amongst many other complications. The identification of homocysteine as a risk factor for cad and stroke carries important public health implications. Hyperhomocysteinemia has been shown to be a mild independent risk factor for premature atherosclerosis, and there is evidence of an increased rate of peripheral vascular. Hyperhomocysteinemia is typically managed with vitamin b6, vitamin b9 and vitamin b12 supplementation. Hyperhomocysteinemia arising from impaired methionine metabolism, probably usually due to a deficiency of cystathionine.
As it has been verified by many studies, even mild hyperhomocysteinemia hhcy may increase the risk for clinical manifestations of stroke, probably due to the pleiotropic biochemical. Epidemiological studies have shown that increased homocysteine plasma concentration hyperhomocysteinemia is related to a higher risk of coronary heart disease, stroke, peripheral. Biochemical determinations were performed at entry t0 and then repeated one month after stroke t1. As a consequence of the biochemical reactions in which homocysteine is involved, deficiencies of vitamin b 6, folic acid vitamin b 9, and vitamin b 12 can lead to high homocysteine levels. Changes in total homocysteine levels after acute stroke and. A high blood level of the sulfurcontaining amino acid. Homocysteine hcys is a key metabolite involved in the biosynthesis and metabolism of methionine met, which plays a pivotal role in the physiological cells life cycle. Hyperhomocysteinemia is a disorder associated with derangements of the metabolic pathway involved in metabolism of the essential amino acid methionine. Hyperhomocysteinemia and the role of b vitamins in cancer in. Hyperhomocysteinemia was present in combination with other types of thrombophilia in 11 patients 4 had also factor v leiden, 4 prothrombin mutation, 1 both, and 2 antiphospholipid. Jul 11, 2014 homocysteine is a naturallyoccurring amino acid produced from a methyl donor, methionine and essential for intracellular metabolism 1. Role of homocysteine in the ischemic stroke and development. Pdf relationship between homocysteine and ischemic stroke.
Role of homocysteine in the ischemic stroke and development of. Impairment of cerebrovascular reactivity by methioneinduced hyperhomocysteinemia and amelioration by quinapril treatment. Soomro, kanwal sartaj, shafaq alvi 1resident, department of medicine, ziauddin medical university hospital. Frontiers hyperhomocysteinemia as a risk factor and. Hyperhomocysteinemia is recognized as a risk factor for several diseases, including cardiovascular and neurological conditions. Several casecontrol studies and even a metaanalysis have confirmed a link between venous thrombosis and hyperhomocysteinemia. Homocystinuria homocystinuria is a disorder of methionine metabolism, leading to an abnormal accumulation of homocysteine and its metabolites homocystine, homocysteinecysteine. Grewal3, marjorie busby4, patricia chang 4 and alan hinderliter 1 department of neurology, university of south carolina school of medicine, columbia, sc, usa 2 the neurogenetics foundation, cranbury, nj, usa. Hyperhomocysteinemia, a new independent risk factor for atherosclerotic vascular disease, has been described in the last ten years. Hyperhomocysteinemia hematology and oncology merck. Vascular function in hyperhomocysteinemia and atherosclerosis.
Hyperhomocysteinemia in chronic renal insufficiency. Hyperhomocysteinemia as a risk factor for deepvein. Hyperhomocysteinemia is associated with aortic atheroma. Prevention remains the optimal strategy to reduce the. Create a free personal account to download free article pdfs, sign up for alerts, and more. Homocysteine is due to genetic and acquired factors poor diet in folate and vitamin b12, older age, renal impairment, thyroid diseases, and malignancies induced by the intake and the concentrations of. Mild hyperhomocysteinemia is a riskfactor in all etiological. Background and purposeelevated blood homocysteine concentration increases the risk of stroke. It is reported that csvd can cause 20% of ischemic strokes and 45% of dementia. Mild hyperhomocysteinemia is an established risk factor for atherosclerosis and vascular disease. The biochemistry of met is finely regulated by several enzymes that control hcys concentration. Frontiers hyperhomocysteinemia as a risk factor for. Contextin observational studies, elevated plasma total homocysteine levels have been positively associated with ischemic stroke risk.
Features, symptoms, and neurophysiological findings in. Severity of symptoms is determined by how high the homocysteine levels are. Hyperhomocysteinemia has been shown to be associated with a number of neurological conditions like stroke,silent brain infarct, dementia, movement disorders, etc. Neural cells are sensitive to prolonged hhcy treatment, because hcy cannot be metabolized either by the transsulfuration pathway or by the folate. The aims of our study were to assess i the association between risk of stroke and increasing values.
Murthy department of neurology, the institute of neurological sciences, care hospital, hyderabad, india. Lowering homocysteine in patients with ischemic stroke to prevent. Association of hyperhomocysteinemia with stroke recurrence after. Modest elevations of plasma homocysteine are independently associated with an increased incidence of venous thrombosis and arterial atherothrombotic diseases, including myocardial infarction and stroke. Oct 31, 2018 behind only alzheimers disease, vascular contributions to cognitive impairment and dementia vcid is the second most common cause of dementia, affecting roughly 1040% of dementia patients. Summary and explanation of test homocysteine hcy is a thiolcontaining amino acid produced by the.
Hyperhomocysteinemia in cerebral vein thrombosis blood. Hyperhomocysteinemia an overview sciencedirect topics. Venous thromboembolism and hyperhomocysteinemia as first. It has a physiologic role in dna metabolism via methylation, a process governed by the presentation of folate, and vitamins b6 and b12.
The role of hyperhomocysteinemia as independent risk factor for stroke needs to be confirmed. Several casecontrol studies and even a metaanalysis have confirmed a link between venous thrombosis and. Hyperhomocysteinemia has been shown to be associated with a number of neurological conditions like stroke,silent brain. Hyperhomocysteinemia as a risk factor for ischemic stroke bioline.
If effective, the simplicity, availability, and presumably favorable side effect profile of hyperhomocysteinemia treatment with combined folic acid and oral b 6 and b 12 vitamin supplementation collectively referred to in. Several epidemiological studies have shown that high levels. Hyperhomocysteinemia, ischemic stroke, and bvitamin. It is often associated with folate or cobalamin deficiency as well as genetic defects. Hyperhomocysteinemia is a risk factor for both myocardial ischemia and ischemic stroke, and alcoholics often have elevated blood homocysteine levels secondary to deficiency of folate, pyridoxine, or cobalamin. Homocysteine is an intermediary amino acid formed by the conversion of methionine to cysteine figure 1. Homocystinuria is a rare autosomal recessive disorder characterized by severe elevations in. Hyperhomocysteinemia and strokethe ruby hall study. Stroke in young patients with hyperhomocysteinemia due to. Impairment of cognitive processing as measured by visual eventrelated potential is more pronounced in hyperhomocysteinemia.
Accumulating data suggest elevated total serum homocysteine thcy is associated with an increased risk of coronary heart disease and stroke. The pathogenic role of hyperhomocysteinemia in cryptogenic stroke is not well established. Murthy department of neurology, the institute of neurological sciences, care hospital, hyderabad, india ischemic stroke has a high prevalence and high burden of illness. Hyperhomocysteinemia, ischemic stroke, and bvitamin treatment. Hyperhomocysteinemia, oxidative stress, and cerebral vascular. Jul 27, 2018 homocystinuria is a disorder of methionine metabolism, leading to an abnormal accumulation of homocysteine and its metabolites homocystine, homocysteinecysteine complex, and others in blood and urine. Hyperhomocysteinemia, obesity and cryptogenic stroke ios. We aimed to determine homocysteine levels in patients with cryptogenic stroke considering the possible variables that may act as confounders and analyze the influence of obesity on this association. A high blood level of the sulfurcontaining amino acid, homocysteine, is a risk factor for cardiovascular disease, stroke, and vascular dementia.
Hyperhomocysteinemia is associated with aortic atheroma progression in stroke tia patients souvik sen1, p. Hyperhomocysteinemia an unidentified risk factor for stroke. Since the homocysteine level is elevated in patients with advanced chronic renal insufficiency, it has been presented as an important factor contributing to the development of cardiovascular complications in these patients. Moderate hyperhomocysteinemia occurs in 57% of general population, and is associated in the third and fourth deceny of life with premature coronary disease, stroke, arterial and venous. Apr 24, 2019 hyperhomocysteinemia is recognized as a risk factor for several diseases, including cardiovascular and neurological conditions. B vitamin deficiency, which is the most common cause of hhcy, is common in the elderly. Hyperhomocysteinemia and the role of b vitamins in cancer. Apr, 2020 hyperhomocysteinemia is a medical condition in which the total plasma homocysteine concentration is abnormally elevated. The prevalence of mild hyperhomocysteinemia was 23% 12. Association of hyperhomocysteinemia with stroke recurrence. Relationship between homocysteine and ischemic stroke bjm vol. Of the 9522 patients with stroke, 307 27% with hyperhomocysteinemia hhcy had recurrent stroke. Elevated plasma levels of homocysteine, termed hyperhomocysteinemia.
1031 1555 75 305 1387 1025 556 1193 651 980 1376 917 705 841 1490 1106 1112 201 1067 553 447 147 259 511 130 387 1086 895 506 1453 625 1437 551 1339 205 804 1054 438 69 1146 1442 481 505 877 746 511 258 991